INTERNATIONAL PATENT: BRANDARIS THERAPEUTICS B.V. FILES APPLICATION FOR "5,6-BICYCLIC 5-HT2AR AGONISTS AND USES THEREOF"

GENEVA, April 20 -- BRANDARIS THERAPEUTICS B.V. (Galileiweg 82333 BD Leiden) filed a patent application (PCT/IB2025/000617) for "5,6-BICYCLIC 5-HT2AR AGONISTS AND USES THEREOF" on Oct 08, 2025. With publication no. WO/2026/078446, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GLOSSOP, Paul (c/o Brandaris Therapeutics B.V.Galileiweg 82333 BD Leiden), MONTANA, John (c/o Brandaris Therapeutics B.V.Galileiweg 82333 BD Leiden), HEAL, Jonathan (c/o Brandaris Therapeutics B.V.Galileiweg 82333 BD Leiden), SHERIDAN, Joseph (c/o ...